Table 3.

Safety outcomes (SAS)

Safety Outcomes	Low-dose group (n = 90)	High-dose group (n = 73)	Control group (n = 75)
All-cause death within 90 days, n (%)	1 (1.1%)	2 (2.7%)	0 (0.0%)
Hemorrhagic transformation after stroke within 90 days, n (%)	0 (0.0%)	2 (2.7%)	1 (1.3%)
Recurrent ischemic stroke within 90 days, n (%)	4 (4.4%)	2 (2.7%)	2 (2.7%)
AEs, n (%)	75 (83.3%)	57 (78.1%)	61 (81.3%)
SAEs, n (%)	9 (10.0%)	4 (5.5%)	7 (9.3%)
Number of deaths, n (%)	1 (1.1%)	2 (2.7%)	0 (0.0%)

AEs indicate adverse events; SAEs, serious adverse events.